Financhill
Back

Synopsys Quote, Financials, Valuation and Earnings

Synopsys Price Quote

$519.43
-7.98 (-1.51%)
(Updated: April 18, 2024 at 6:55 PM ET)

Synopsys Key Stats

Sell
49
Synopsys (SNPS) is a Sell

Day range:
$525.77 - $546.67
52-week range:
$360.37 - $629.38
Dividend yield:
0%
P/E ratio:
66.61
P/S ratio:
13.35
P/B ratio:
12.06%

Volume:
988.6K
Avg. volume:
947.4K
1-year change:
38.72%
Market cap:
$80.5B
Revenue:
$5.8B
EPS:
$9.08

How Much Does Synopsys Make?

  • How Much Are Synopsys's Sales Annually?
    SNPS Revenues are $5.8B
  • How Much Profit Does Synopsys's Make A Year?
    SNPS net income is $1.2B

Is Synopsys Growing As A Company?

  • What Is Synopsys's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.21%
  • What Is Synopsys's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0.65%

Synopsys Stock Price Performance

  • Did Synopsys Stock Go Up Last Month?
    Synopsys share price went down by -4.11% last month
  • Did SNPS's Share Price Rise Over The Last Year?
    SNPS share price rose by 38.72% over the past 1 year

What Is Synopsys 52-Week High & Low?

  • What Is Synopsys’s 52-Week High Share Price?
    Synopsys has traded as high as $629.38 over the past 52 weeks
  • What Is Synopsys’s 52-Week Low Share Price?
    Synopsys has traded as low as $360.37 over the past 52 weeks

Synopsys Price To Free Cash Flow

  • Is Synopsys Stock Overvalued?
    Synopsys is trading at a price to free cash flow ratio of 62.34
  • Is Synopsys Stock Undervalued?
    Synopsys EV to Free Cash Flow ratio is 61.93
  • What Is Synopsys’s Price Earnings Growth Ratio?
    SNPS PEG ratio is 1.17
  • Is Synopsys Trading At A Premium To Earnings?
    Synopsys EV to EBIT ratio is 54.56

Is It Risky To Buy Synopsys?

  • How Much Debt Does Synopsys Have?
    Total long term debt quarterly is $17M
  • How Much Cash Does Synopsys Have?
    Cash and short term investments quarterly total is $1.3B
  • What Is Synopsys’s Book Value Per Share?
    Book value per share is 43.73

Is Synopsys Cash Flow Positive?

  • What Is SNPS Cash Flow From Operations?
    Cash flow from operations (TTM) is $1.5B
  • What Is Synopsys’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$1B
  • What Is Synopsys’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$500.3M

Synopsys Return On Invested Capital

  • Is Management Doing A Good Job?
    SNPS return on invested capital is 23.05%
  • What Is Synopsys Return On Assets?
    ROA measures how assets are converting to revenues and is 14.03%
  • What Is SNPS Return On Equity?
    ROE is a measure of profitability and is 23.12%

Synopsys Earnings Date & Stock Price

  • What Is Synopsys's Stock Price Today?
    A single share of SNPS can be purchased today for 527.41
  • What Is Synopsys’s Stock Symbol?
    Synopsys trades on the nasdaq under the ticker symbol: SNPS
  • When Is Synopsys’s Next Earnings Date?
    The next quarterly earnings date for Synopsys is scheduled on May 17, 2024
  • When Is SNPS's next ex-dividend date?
    Synopsys's next ex-dividend date is June 24, 2020
  • How To Buy Synopsys Stock?
    You can buy Synopsys shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

Synopsys Competitors

  • Who Are Synopsys's Competitors?
    Below is a list of companies who compete with Synopsys or are related in some way:
    • Ansys Inc (ANSS)
    • Cadence Design Systems Inc (CDNS)
    • Salesforce Inc (CRM)
    • Intuit Inc (INTU)
    • Microsoft Corp (MSFT)

Synopsys Dividend Yield

Data Unavailable

Synopsys Analyst Estimates

YoY Growth Past Surprise
EPS: 65.14% 4.26%
Revenue: 21.15% 0.26%

Analyst Recommendations

Buy Recommendations: 11
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 632.47
Upside from Last Price: 19.92%

Major Shareholders

  • How many SNPS shares are owned by institutional investors?
    215.5M SNPS shares are owned by institutional investors
  • How many SNPS shares are owned by insiders?
    913.6K SNPS shares are owned by insiders